Lyrica

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68258-7047		I	Inactivated by FDA		2026-07-31
excluded package	package	68258-7047	68258-7047-3	I	Inactivated by FDA		2026-07-31

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
441d8579-bd15-4585-93f4-9de3db2d851d	Product name	4	20251114
004d1029-ec13-fc89-74f4-3907cf5b6602	Product name	2	20140523

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68258-7047-3	2019-11-27	C162847	48780-1	9855d018-e312-cd31-e053-dbdaa90ab51a	These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 2004

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68258-7047-3	Lyrica	30 in 1 BOTTLE, PLASTIC	CAPSULE	30		2

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PREGABALIN	ACTIVE INGREDIENT	55JG375S6M	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
PREGABALIN	ACTIVE MOIETY	55JG375S6M	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68258-7047	LYRICA (PREGABALIN) CAPSULE [DISPENSING SOLUTIONS, INC.]	2	Legacy NDC, 1 package rows	20130718_5bdc51aa-420b-4a59-a69f-a0c19726cd87.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
55JG375S6M	PREGABALIN	148553-50-8	PREGABALIN

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
607020	Lyrica 150 MG Oral Capsule	PSN	5bdc51aa-420b-4a59-a69f-a0c19726cd87	2
483440	pregabalin 150 MG Oral Capsule	PSN	5bdc51aa-420b-4a59-a69f-a0c19726cd87	2
607020	pregabalin 150 MG Oral Capsule [Lyrica]	SBD	5bdc51aa-420b-4a59-a69f-a0c19726cd87	2
483440	pregabalin 150 MG Oral Capsule	SCD	5bdc51aa-420b-4a59-a69f-a0c19726cd87	2
607020	Lyrica 150 MG Oral Capsule	SY	5bdc51aa-420b-4a59-a69f-a0c19726cd87	2

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68258-7047-3	68258704703	30 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lyrica	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-07-17	HUMAN PRESCRIPTION DRUG LABEL	2